NCT07851818Not yet recruiting
Screening Psychosocial Distress in Head and Neck Cancer
Psychosocial Distress Screening in Patients Treated for Head and Neck Cancer : The Value of Screening in Speech-Language Therapy Practice
Source: ClinicalTrials.gov · Last updated 1 Oct 2026
Brief summary (registry, in English)
This prospective, multicenter study aims to assess the presence of psychosocial distress using the Distress Thermometer in patients treated for head and neck cancer at the initiation of their speech-language therapy. It also seeks to evaluate the evolution of this distress over a two-month period, as well as its correlation with patient engagement in therapy, functional disorders, and overall quality of life (assessed using the EORTC QLQ-C30 and QLQ-HN35 questionnaires). By capturing longitudinal changes in distress levels, functional impairments, and patient commitment to therapy, this research seeks to clarify the SLP's role in comprehensive supportive oncology care and optimize timely psychological referrals for vulnerable patients. The study hypothesizes that a significant proportion of patients experience clinically meaningful psychosocial distress (score ≥ 4 on the Distress Thermometer) at the start of speech-language therapy. It is also expected that this distress correlates with lower therapeutic engagement and impaired quality of life, and that early screening by speech-language pathologists will improve the timely referral of patients to psychological support professionals.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 21 Sept 2026
- Start date
- 30 Nov 2026
- Primary completion date
- 30 Nov 2027
- Lead sponsor
- Hôpital NOVO
- Diseases
- Head and neck cancer
- NCT number
- NCT07851818
What you commit to
- Study type: Observational
- Planned participants: 80
- From 30 Nov 2026 to the primary completion date, 30 Nov 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment preventing the completion of the questionnaire
- Clinical condition preventing participation
- Severe, unstabilized psychiatric disorders
Other
- Palliative care initiated
Who the study is looking for
- Adult patients aged 18 years or older
- Patients managed following a diagnosis of squamous cell carcinoma of the upper aerodigestive tract
- Requiring speech-language pathology care
- Initiation of curative-intent treatment dating back less than one month
- Sufficient understanding of the French language to complete the study questionnaires
- Patient who has been informed about the research and has not expressed any objection to participating
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.